{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:28:26Z","timestamp":1790692106098,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170710"],"award-info":[{"award-number":["82170710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.intimp.2022.109234","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:54:27Z","timestamp":1663055667000},"page":"109234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Complement factor H variants are associated with microangiopathy lesions in IgA nephropathy"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-6455","authenticated-orcid":false,"given":"Wanyin","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10032","key":"10.1016\/j.intimp.2022.109234_b0005","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/S0140-6736(16)00272-5","article-title":"Primary glomerulonephritides","volume":"387","author":"Floege","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2022.109234_b0010","doi-asserted-by":"crossref","unstructured":"Y. Tsukamoto, H. Wang, G. Becker, H.C. Chen, D.S. Han, D. Harris, E. Imai, V. Jha, P.K. Li, E.J. Lee, S. Matsuo, Y. Tomino, K. Tungsanga, K. Yamagata, A. Hishida, Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. \u201cCurrent status and perspective of CKD in Asia\u201d: diversity and specificity among Asian countries, Clin Exp Nephrol 13(3) (2009) 249-56.","DOI":"10.1007\/s10157-009-0156-8"},{"issue":"245","key":"10.1016\/j.intimp.2022.109234_b0015","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"64","author":"D'Amico","year":"1987","journal-title":"Q J Med"},{"issue":"5","key":"10.1016\/j.intimp.2022.109234_b0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.ajkd.2019.03.416","article-title":"Microangiopathic Lesions in IgA Nephropathy: A Cohort Study","volume":"74","author":"Cai","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.intimp.2022.109234_b0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1681\/ASN.2010111130","article-title":"A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy","volume":"23","author":"El Karoui","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.intimp.2022.109234_b0030","first-page":"41","article-title":"Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience","volume":"2","author":"Nasri","year":"2013","journal-title":"J Renal Inj Prev"},{"issue":"6","key":"10.1016\/j.intimp.2022.109234_b0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","article-title":"Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases","volume":"29","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.intimp.2022.109234_b0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.intimp.2022.109234_b0045","doi-asserted-by":"crossref","unstructured":"P. Neves, R.A. Souza, F.M. Torres, F.A. Reis, R.B. Pinheiro, C.B. Dias, L. Yu, V. Woronik, L.S. Furukawa, L.B. Cavalcante, S. de Almeida Araujo, D.C. Wanderley, D.M. Malheiros, L.B. Jorge, Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy, PLoS One 15(11) (2020) e0233199.","DOI":"10.1371\/journal.pone.0233199"},{"issue":"4","key":"10.1016\/j.intimp.2022.109234_b0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/ndt\/gfz241","article-title":"Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy","volume":"36","author":"Trimarchi","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.intimp.2022.109234_b0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","article-title":"Current Understanding of the Role of Complement in IgA Nephropathy","volume":"26","author":"Maillard","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.intimp.2022.109234_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/ng.1047","article-title":"A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy","volume":"44","author":"Yu","year":"2011","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.intimp.2022.109234_b0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.intimp.2022.109234_b0070","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1681\/ASN.2010010076","article-title":"HLA has strongest association with IgA nephropathy in genome-wide analysis","volume":"21","author":"Feehally","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.intimp.2022.109234_b0075","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/bi00270a026","article-title":"Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I","volume":"22","author":"Pangburn","year":"1983","journal-title":"Biochemistry"},{"issue":"22","key":"10.1016\/j.intimp.2022.109234_b0080","doi-asserted-by":"crossref","first-page":"16666","DOI":"10.1074\/jbc.M001123200","article-title":"Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack","volume":"275","author":"Fedarko","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.intimp.2022.109234_b0085","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ekir.2022.03.028","article-title":"The Role of Complement in Microangiopathic Lesions of IgA Nephropathy","volume":"7","author":"Li","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.intimp.2022.109234_b0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1681\/ASN.2020060823","article-title":"Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy","volume":"32","author":"Wang","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.intimp.2022.109234_b0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mpdhp.2013.02.004","article-title":"Thrombotic microangiopathy and the kidney: a nephropathologist's perspective","volume":"19","author":"Chang","year":"2013","journal-title":"Diagnostic Histopathology"},{"key":"10.1016\/j.intimp.2022.109234_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/680502","article-title":"Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China","volume":"2014","author":"Yu","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"21","key":"10.1016\/j.intimp.2022.109234_b0105","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.1073\/pnas.1019338108","article-title":"Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk","volume":"108","author":"Heurich","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.intimp.2022.109234_b0110","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.amjms.2018.04.006","article-title":"Coding and Noncoding Variants in CFH Act Synergistically for Complement Activation in Immunoglobulin A Nephropathy","volume":"356","author":"Guo","year":"2018","journal-title":"Am J Med Sci"},{"issue":"5720","key":"10.1016\/j.intimp.2022.109234_b0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2022.109234_b0120","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.intimp.2022.109234_b0125","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng1871","article-title":"CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration","volume":"38","author":"Li","year":"2006","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.intimp.2022.109234_b0130","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1093\/hmg\/ddt336","article-title":"Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration","volume":"22","author":"Ansari","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.intimp.2022.109234_b0135","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng1890","article-title":"A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration","volume":"38","author":"Hughes","year":"2006","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.intimp.2022.109234_b0140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"H.U.S. European Working Party on the Genetics of, The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.intimp.2022.109234_b0145","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.intimp.2022.109234_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040355","article-title":"Neovascular age-related macular degeneration risk based on CFH, LOC387715\/HTRA1, and smoking","volume":"4","author":"Hughes","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.intimp.2022.109234_b0155","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1681\/ASN.2015111210","article-title":"Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese","volume":"27","author":"Xie","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.intimp.2022.109234_b0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodriguez de Cordoba","year":"2004","journal-title":"Mol Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2022.109234_b0165","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1681\/ASN.2014050429","article-title":"Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy","volume":"26","author":"Chua","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.intimp.2022.109234_b0170","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41379-019-0259-z","article-title":"Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis","volume":"32","author":"Chua","year":"2019","journal-title":"Mod Pathol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922007184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922007184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:42Z","timestamp":1761586962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922007184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":34,"alternative-id":["S1567576922007184"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109234","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complement factor H variants are associated with microangiopathy lesions in IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109234"}}